Please login to the form below
urology
This page shows the latest urology news and features for those working in and with pharma, biotech and healthcare.
FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
Patients with BCG-unresponsive NMIBC have historically had limited treatment options other than bladder removal surgery,” said Steven Boorjian, Carl Rosen professor and chair of the Department of Urology at Mayo
Latest news
-
Galen completes acquisition of healthcare company POA Pharma
Galen is headquartered in Craigavon, Northern Ireland, and has products in therapy areas including gastroenterology, urology, female health, pain management and mental health.
-
Private equity firm backs Ferring gene therapy venture
The Swiss company’s main activities lie in speciality therapeutics for women’s health, gastroenterology and urology.
-
Daily Brief: Immunotherapy combos dominate ASCO, Pharma's Brexit warning, Big data and prostate cancer
The consortium is being jointly led by Prof. James N’Dow from the European Association of Urology/University of Aberdeen (pictured) and Dr.
-
The power of pharma businesses to drive social change
We wanted to build the programme on the foundation of our expertise in urology and commitment to building access to medicine.
-
Roivant gets $1.1bn investment from Japan's SoftBank
Roivant - the holding company for subsidiaries Axovant, Myovant, Dermavant, Enzyvant and just-launched urology specialist Urovant - said the cash injection will be used to launch new subsidiaries "within and beyond the
More from news
Approximately 2 fully matching, plus 70 partially matching documents found.
Latest Intelligence
-
Cutting through the noise: CRISPR
Luke Gilbert, assistant professor in the Department of Urology, the Helen Diller Family Comprehensive Cancer Center and the IGI at University of California, San Francisco, explains how the CRISPR-focused collaboration
-
Case study: Action on Fistula
Astellas wanted to identify how best to create a corporate giving initiative which would leverage its expertise in urology and commitment to building access to medicines.
-
Astellas: Ten years young
diff. Alongside these launches the company has been moving into the oncology arena, adding to its legacy interest in urology from Yamanouchi and Fujisawa, and transplantation, where it has Prograf (tacrolimus) ... We have a legacy, an expertise in urology
-
Deal Watch table for October 2014
Auxilium/Endo. Company acquisition. Urology and orthopaedic products including alprostadil for ED.
-
Pharma deals during April 2014
Lilly will continue to focus on prescription drugs (diabetes, oncology, neuroscience, cardiovascular, urology etc) but will now also have a world leading position in Animal Health.
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Astellas strengthens US and Canadian leadership team
His continued leadership and extensive experience in sales and marketing will help ensure that our ongoing commitment to therapies in oncology, urology, immunology and other areas will focus on Canadian patients’
-
Paul Navarre moves from Allergan to Ferring Pharmaceuticals
business covering dermatology, ophthalmology, urology and neurosciences.
-
Astellas appoints new senior VP
Dodson has previously worked for Pfizer in various medical affairs leadership roles spanning the urology and respiratory franchises and has served GTx as its vice president of medical affairs.
-
Former Astellas regulatory lead joins Oxular
Waters brings over 15 years of expertise in the development and registration of products in ophthalmology to the firm, most recently as global regulatory lead for urology and ophthalmology projects at
-
Astellas names Bob Chib to development leadership role
Chib, who previously led Astellas' Strategic Accounts Business Unit, joined the firm in 2004 as associate director, urology and primary care marketing.
More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide.
-
Red Consultancy expands healthcare team with three new hires
Her experience spans urology, oncology, diabetes, dermatology, above brand corporate campaigns and international work.
-
Porterhouse Medical Group adds to its growing team of scientific and medical experts
Claire also has plenty of experience managing digital projects and events across a range of therapy areas, including women’s health, diabetes, haematology, oncology, urology, dermatology and asthma.
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
Innovative NHS suppliers scoop HSJ Partnership Awards
Best Healthcare Provider to the NHS: Winner, Circle Health. Best Innovation in Medical Technology: Winner Bruin Biometrics; highly commended, Endomagnetics Limited &Neotract Teleflex Interventional Urology.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- EU outlines measures to mitigate antibiotic shortage across Europe
- Europe’s cancer community publishes new report on transforming patient care
- Meeting healthcare’s rising challenges
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Tidepool’s automated insulin dosing app for type 1 diabetes gets FDA approval
- UK to introduce new regulatory framework for point of care manufacturing
- Navigating the patient experience to improve retention of clinical trial participants
- Europe’s cancer community publishes new report on transforming patient care
- Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- EU to revise pharmaceuticals law amid antibiotic shortages
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Why everyone in pharma is bending over backwards to be agile
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
